Delivery Order SPE2DB20D3101-SPE2DB24FQWP0
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,585.28 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract is for the supply of Lantus Solostar 100 unit/mL 3 mL, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,868.40 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL medication. The contract has an ultimate completion date of October 30, 2024 and was not set aside for any specific business category. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $2,733.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to support government healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,555,366,708 units of Lantus Solostar 100 unit/mL 3mL. The $1,424.64 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is a delivery order for the provision of Lantus Solostar 100 Unit/ML 3ML medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,179.15 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Lantus Solostar 100 unit/mL 3mL injectors. The $1,187.60 award has a performance period ending on February 5, 2024. This delivery order is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,654.42 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $11,784.92 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the supply of Lantus Solostar 100 unit/ML 3ML, a specialty pharmaceutical product, with a period of performance through March 27, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQWP0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,246.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., valued at up to $999,999,999.00, which provides comprehensive pharmaceutical and medical supply support to the Department of Defense and other federal healthcare programs. The contract is not subject to any set-aside requirements, indicating open competition. AmerisourceBergen's extensive pharmaceutical distribution capabilities and existing IDCs with agencies such as the DLA and Department of Justice enable it to efficiently deliver essential medical commodities, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to support military and federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/11/23 |